Abstract
Purpose
Methods
Results
Conclusions
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical ImagingReferences
- Enlargement of the inferior olivary nucleus in association with lesions of the central tegmental tract or dentate nucleus.Brain. 1961; 84: 341-361
- Hypertrophic olivary degeneration: metaanalysis of the temporal evolution of MR findings.AJNR Am J Neuroradiol. 2000; 21: 1073-1077
- Hypertrophic olivary degeneration after surgical removal of cavernous malformations of the brain stem: report of four cases and review of the literature.Acta Neurochir (Wien). 2008; 150 ([discussion 56]): 149-156
- Hypertrophic olivary degeneration following pontine haemorrhage: hypertensive crisis or cavernous haemangioma bleeding?.J Neurol Neurosurg Psychiatry. 2003; 74: 797-799
- Hypertrophic olivary degeneration: case report in a child.Pediatr Radiol. 1998; 28: 830-831
- Collision in the inferior olive: hypertrophic olivary degeneration complicated by radiation necrosis in brainstem primitive neuroendocrine tumor.Clin Imaging. 2012; 36: 371-374
- Hypertrophic olivary degeneration: MR imaging and pathologic findings.Radiology. 1994; 192: 539-543
- Hypertrophic olivary degeneration in children: four new cases and a review of the literature with an emphasis on the MRI findings.Br J Radiol. 2012; 85: 511-516
- Hypertrophic olivary degeneration after surgical resection of brain tumors.Acta Radiol. 2013; 54: 462-466
- Diffusion tensor imaging in hypertrophic olivary degeneration.AJNR Am J Neuroradiol. 2010; 31: 1729-1731
Article info
Publication history
Footnotes
☆Funding: Miki Hirano was supported by a Medical Student Summer Fellowship from the Brain Tumor Center of Memorial Sloan Kettering Cancer Center.
☆☆Authorship: Design and conceptualization of the study (SK, RJY), analysis and interpretation of the data (MK, VH, SK, RJY), drafting and revising the manuscript (MK, VH, SK, RJY), and final approval of submitted version (MK, VH, SK, RJY).
★Financial disclosures: All authors report no disclosures.